Table 3.
Stratified analyses | No. of patients | No. of studies | Model | Pooled HR (95% CI) | P-value | PD-value | Heterogeneity | |
---|---|---|---|---|---|---|---|---|
I2 | PH-value | |||||||
Assessment time | <0.001 | |||||||
Short-term mortality | ||||||||
In-hospital mortality | 2,642 | 4 | Fixed | 1.051 (1.029–1.072) | 0.005 | 44.8% | 0.142 | |
30-day mortality | 151 | 1 | Random | 1.220 (1.105–1.347) | <0.001 | - | - | |
60-day mortality | 255 | 1 | Random | 3.300 (1.350–8.068) | 0.009 | - | - | |
90-day mortality | 1,437 | 4 | Random | 1.115 (0.913–1.362) | 0.284 | 72.4% | 0.013 | |
Long-term mortality* | 468 | 2 | Random | 1.030 (1.010–1.050) | 0.003 | 0.0% | 0.423 | |
Demographic factors | ||||||||
Age | <0.001 | |||||||
<65 | 935 | 4 | Random | 1.052 (0.997–1.110) | 0.065 | 55.4% | 0.047 | |
≥65 | 3,656 | 7 | Random | 1.131 (1.042–1.227) | 0.003 | 77.3% | <0.001 | |
Gender distribution | <0.001 | |||||||
Male dominant | 2,919 | 4 | Fixed | 1.039 (1.024–1.053) | <0.001 | 23.8% | 0.263 | |
Balanced | 1,577 | 6 | Random | 1.170 (1.016–1.347) | 0.030 | 70.8% | 0.002 | |
Female dominant | 95 | 1 | Random | 1.339 (1.050–1.708) | 0.019 | - | - | |
Country | <0.001 | |||||||
Eastern | 2,560 | 4 | Random | 1.046 (1.017–1.077) | 0.002 | 57.5% | 0.052 | |
Western | 2,031 | 7 | Random | 1.168 (1.018–1.339) | 0.027 | 66.0% | 0.004 | |
Vascular risk factors | ||||||||
Presence of hypertension | <0.001 | |||||||
<55% | 257 | 2 | Fixed | 1.198 (1.088–1.321) | <0.001 | 45.3% | 0.161 | |
≥55% and <65% | 1,658 | 4 | Random | 1.162 (0.986–1.370) | 0.074 | 59.9% | 0.058 | |
≥65% and <75% | 1,731 | 1 | Random | 1.040 (1.015–1.065) | 0.001 | |||
≥75% | 734 | 2 | Random | 1.045 (1.001–1.090) | 0.044 | 61.7% | 0.074 | |
Presence of diabetes mellitus | <0.001 | |||||||
<25% | 2,034 | 4 | Fixed | 1.043 (1.026–1.060) | <0.001 | 48.1% | 0.103 | |
≥25% | 2,240 | 4 | Random | 1.167 (1.012–1.347) | 0.034 | 83.9% | <0.001 | |
Presence of hyperlipidemia | 0.006 | |||||||
<25% | 619 | 3 | Random | 1.076 (1.013–1.143) | 0.018 | 73.2% | 0.005 | |
≥25% | 2,030 | 5 | Random | 1.125 (0.944–1.342) | 0.189 | 60.2% | 0.040 | |
Presence of current smoking | 0.214 | |||||||
<35% | 2,591 | 4 | Random | 1.167 (0.972–1.402) | 0.098 | 81.0% | 0.001 | |
≥35% | 372 | 1 | Random | 0.660 (0.356–1.222) | 0.186 | |||
Methodological factors | ||||||||
Onset-time# | <0.001 | |||||||
Within 24 h | 1,355 | 4 | Random | 1.174 (1.043–1.321) | 0.008 | 73.7% | 0.010 | |
Within 48 h | 2,547 | 3 | Fixed | 1.039 (1.024–1.054) | <0.001 | 5.3% | 0.367 | |
Sample time& | 0.001 | |||||||
On admission | 2,208 | 7 | Random | 1.083 (1.020–1.151) | 0.010 | 75.3% | <0.001 | |
Within 24 h | 198 | 2 | Fixed | 1.222 (1.083–1.379) | 0.396 | 0.0% | 0.001 | |
Within 48 h | 2,185 | 2 | Fixed | 1.040 (1.015–1.065) | 0.001 | 0.0% | 0.896 | |
Cutoff value | 0.019 | |||||||
<4 | 1,837 | 2 | Fixed | 1.039 (1.014–1.065) | 0.002 | 0.0% | 0.403 | |
≥4 | 1,174 | 6 | Random | 1.308 (1.103–1.551) | 0.002 | 56.0% | 0.045 | |
Definition of cutoff value | <0.001 | |||||||
ROC curve analysis | 2,302 | 6 | Random | 1.155 (1.012–1.319) | 0.033 | 76.0% | <0.001 | |
Continuous variable | 1,580 | 3 | Random | 1.054 (1.017–1.092) | 0.004 | 61.0% | 0.053 | |
Median | 255 | 1 | Random | 3.300 (1.350–8.068) | 0.009 | - | − | |
ORs/RRs calculation‡ | <0.001 | |||||||
Multivariate | 4,485 | 10 | Random | 1.085 (1.042–1.130) | <0.001 | 73.6% | <0.001 | |
Univariate | 106 | 1 | Fixed | 0.725 (0.429–1.225) | 0.229 | 0.0% | 0.979 |
Long-term mortality was defined as hazard of death due to all causes or stroke within at least 1 year by the end of follow-up.
Onset time was defined as time from stroke onset to recruitment/admission/diagnosis.
Sample time was defined as time from stroke onset to take blood sample.
HRs were extracted from multivariate Cox proportional hazards models, univariate Cox proportional hazards models, or survival curve analysis.